NCT00442260View on ClinicalTrials.gov

Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Metastatic Breast Cancer
Interventions
DRUG

DOXIL

DRUG

Abraxane

Trial Locations (1)

26506-9260

Clinical Trials Research Unit, West Virginia University, Morgantown

Sponsors

Collaborators (1)

Ortho Biotech, Inc.
All Listed Sponsors
collaborator

Ortho Biotech, Inc.

INDUSTRY

lead

West Virginia University

OTHER